![]() Morgan Stanley, Jefferies, TD Cowen and Piper Sandler are acting as joint book-running managers for the offering. IPOs, excluding listings for special purpose acquisition companies, is down about 22% to a total of just $2.35 billion year-to-date, according to Dealogic, as the volatility in stock market and economic uncertainty had put many IPO hopefuls off.įollowing the completion of offering, Acelyrin will be listed on the Nasdaq with its shares trading under the ticker symbol "SLRN". filed for an initial public offering (IPO) in the. stock market listing, setting stage for largest IPO offering of the year. Chinese medical data group LinkDoc Technology Ltd has shelved its listing in the United States to raise up to 211 million following Beijing's. Last week, SoftBank's (9984.T) ARM Ltd filed with regulators confidentially for a U.S. Johnson & Johnson Inc (JNJ.N) is preparing to list its consumer health business Kenvue Inc (KVUE.N) in New York this Friday, hoping to raise about $3.5 billion. There are signs that the IPO market is beginning to thaw. ![]() The Los Angeles-based company is aiming to raise up to roughly $370 million, by selling 20.6 million shares at nearly the top-end of its proposed price range of $16 to $18 per share, the company said in a filing. May 1 (Reuters) - Late-stage clinical biopharma company Acelyrin Inc (SLRN.O) said on Monday that it was seeking a valuation of up to $1.5 billion in its initial public offering in the United States that comes at a time when new listings are testing investors' appetite.
0 Comments
Leave a Reply. |